Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
FEBS Letters|June 28, 2003
Regulation of Tiam1-Rac signallingAlexander E Mertens, Rob C Roovers, John G CollardCurrent Opinion in Molecular Therapeutics|August 19, 2007
Nanobodies in therapeutic applicationsRob C Roovers, Guus A M S van Dongen, Paul M P van Bergen en HenegouwenStructure (London, England : 1993)|June 25, 2013
Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domainsKarl R Schmitz, Atrish Bagchi, Rob C Roovers, et al.Journal of Immunological Methods|December 2, 2008
Selection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expressionRinse Klooster, Michael R Eman, Quint le Duc, et al.Mabs|July 30, 2016
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli displayValencio Salema, Carmen Mañas, Lidia Cerdán, et al.Journal of Cell Science|August 15, 2013
Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motifRaimond Heukers, Jeroen F Vermeulen, Farzad Fereidouni, et al.Nature Structural & Molecular Biology|October 25, 2011
ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand bindingShalini T Low-Nam, Keith A Lidke, Patrick J Cutler, et al.Cancer Immunology, Immunotherapy : CII|June 2, 2006
Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR NanobodiesRob C Roovers, Toon Laeremans, Lieven Huang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 6, 2010
Downregulation of EGFR by a novel multivalent nanobody-liposome platformSabrina Oliveira, Raymond M Schiffelers, Joris van der Veeken, et al.Molecular Imaging|March 16, 2012
Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobodySabrina Oliveira, Guus A M S van Dongen, Marijke Stigter-van Walsum, et al.Pageof 4